Hans S. Keirstead
Fondateur chez AiVita Biomedical, Inc.
Profil
Hans S.
Keirstead is the founder of AiVita Biomedical, Inc. (founded in 2016) where he holds the title of Chief Executive Officer & Director.
He is currently the Chairman at Immunis, Inc. and a Director at Pattern Pharma, Inc. Dr. Keirstead has previously worked as a Director at SFC Co., Ltd.
and AEON Biopharma Sub, Inc. He has an undergraduate degree from the University of Cambridge and a doctorate degree from the University of British Columbia.
Postes actifs de Hans S. Keirstead
| Sociétés | Poste | Début |
|---|---|---|
AiVita Biomedical, Inc.
 AiVita Biomedical, Inc. Pharmaceuticals: MajorHealth Technology AiVita Biomedical, Inc. operates as a therapeutic development company which focuses on regenerative and curative medicines. Its products include Provoque facial serum and Provoque eye complex. The company was founded by Hans S. Keirstead in 2016 and is headquartered in Irvine, CA. | Fondateur | 01/01/2016 |
Pattern Pharma, Inc.
 Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Immunis, Inc.
 Immunis, Inc. Miscellaneous Commercial ServicesCommercial Services Immunis, Inc. is a biotechnology company that focuses on developing innovative STEM treatments for immune decline related to age and disease, such as osteoporosis, osteoarthritis, and sarcopenia. The company is based in Irvine, CA. The company is currently conducting clinical trials for participants with leg muscle atrophy or weakness due to osteoarthritis/sarcopenia. Immunis aims to change the course of immune-related diseases and aging. | Président | - |
Anciens postes connus de Hans S. Keirstead
| Sociétés | Poste | Fin |
|---|---|---|
| SFC CO LTD | Directeur/Membre du Conseil | 01/04/2020 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Directeur/Membre du Conseil | - |
Formation de Hans S. Keirstead
| University of Cambridge | Undergraduate Degree |
| University of British Columbia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
SFC Co., Ltd.
 SFC Co., Ltd. Containers/PackagingProcess Industries SFC Co., Ltd. engages in the manufacture and sale of solar module components back sheets, and other films. The company operates through the following business areas: Solar, Film, Energy, and Bio. It offers products such as back sheets, coating films, and others The company was founded on December 23, 1991 and is headquartered in Hongseong-gun, South Korea. | Process Industries |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
AiVita Biomedical, Inc.
AiVita Biomedical, Inc. Pharmaceuticals: MajorHealth Technology AiVita Biomedical, Inc. operates as a therapeutic development company which focuses on regenerative and curative medicines. Its products include Provoque facial serum and Provoque eye complex. The company was founded by Hans S. Keirstead in 2016 and is headquartered in Irvine, CA. | Health Technology |
Pattern Pharma, Inc.
Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. | Health Technology |
Immunis, Inc.
Immunis, Inc. Miscellaneous Commercial ServicesCommercial Services Immunis, Inc. is a biotechnology company that focuses on developing innovative STEM treatments for immune decline related to age and disease, such as osteoporosis, osteoarthritis, and sarcopenia. The company is based in Irvine, CA. The company is currently conducting clinical trials for participants with leg muscle atrophy or weakness due to osteoarthritis/sarcopenia. Immunis aims to change the course of immune-related diseases and aging. | Commercial Services |